Society for Maternal-Fetal Medicine (SMFM) Consult Series | #40
The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention

https://doi.org/10.1016/j.ajog.2016.04.027Get rights and content

Preterm birth remains a major cause of neonatal death and short and long-term disability in the US and across the world. The majority of preterm births are spontaneous and cervical length screening is one tool that can be utilized to identify women at increased risk who may be candidates for preventive interventions. The purpose of this document is to review the indications and rationale for cervical length screening to prevent preterm birth in various clinical scenarios. The Society for Maternal-Fetal Medicine recommends (1) routine transvaginal cervical length screening for women with singleton pregnancy and history of prior spontaneous preterm birth (GRADE 1A); (2) routine transvaginal cervical length screening not be performed for women with cervical cerclage, multiple gestation, preterm premature rupture of membranes, or placenta previa (GRADE 2B); (3) practitioners who decide to implement universal cervical length screening follow strict guidelines (GRADE 2B); (4) sonographers and/or practitioners receive specific training in the acquisition and interpretation of cervical imaging during pregnancy (GRADE 2B).

Section snippets

What is the clinical significance of a sonographically short cervix?

Women with a history of a prior spontaneous PTB account for only 10% of all births < 34 weeks of gestation.2, 3 Thus, researchers and clinicians have studied a variety of factors separate from past pregnancy history in order to further risk-stratify women and attempt to identify those at highest risk for PTB. Currently, mid-trimester CL assessment by transvaginal ultrasound is the best clinical predictor of spontaneous PTB.4 Depending on the population studied and the gestational age of

Should the cervical length be evaluated by transabdominal or transvaginal ultrasound?

Transvaginal ultrasound is considered the ‘gold standard’ measurement when assessing CL. In contrast to transabdominal ultrasound, transvaginal ultrasound measurements are highly reproducible, and measurements are unaffected by maternal obesity, cervical position, and shadowing from fetal parts.8, 9, 10, 11

Transvaginal ultrasound is also more sensitive than transabdominal ultrasound using CL cutoffs typically used to screen for a short cervix.12 For example, the sensitivity using transabdominal

What steps should be performed to accurately evaluate the cervical length?

With the woman’s bladder emptied, the vaginal transducer should be inserted into the anterior fornix of the vagina and positioned so that the endocervical canal is visualized. The ultrasound probe should be gradually withdrawn until the image is just visible to ensure there is not excessive pressure on the probe. A minimum of 3 CL measurements should be obtained by placing calipers at the internal and external os. The shortest, best measurement should be recorded.16, 17, 18 (Box 1)

Ideally,

If the cervical length is assessed by ultrasound, when during pregnancy should it be evaluated?

If transvaginal CL screening is performed, the cervix should be assessed between 16 and 24 weeks gestation. It should not be routinely measured prior to 16 weeks of gestation.21 Prior to this time, the lower uterine segment is underdeveloped, making it challenging to distinguish this area from the endocervical canal. In fact studies evaluating first and early second trimester CL had not consistently shown adequate predictive value of CL measurement for preterm birth.22, 23, 24, 25

Routine CL

How should the approach to cervical length screening differ for women with and without a prior preterm birth?

The approach to CL screening varies based on patient characteristics and risk factors. Current SMFM and American College of Obstetricians and Gynecologists (ACOG) guidelines recommend women with a prior spontaneous PTB undergo CL screening with transvaginal ultrasound.10, 11 Serial assessment of CL is usually performed (every 1-2 weeks as determined by the clinical situation) from 16 until 24 weeks of gestation. We recommend routine transvaginal CL screening for women with singleton pregnancy

Should women with a history of treatment for cervical dysplasia (in the absence of a prior preterm birth) undergo routine serial cervical length screening?

There is insufficient evidence to support additional screening for women with a previous electrosurgical procedure (loop electrical excision procedure, LEEP) or cold knife cone for cervical dysplasia.

A recent large retrospective cohort study, as well as a systematic review and meta- analysis, found that while average CL is shorter in women after a procedure, most nevertheless have a normal mid-trimester CL and more importantly, the increased risk of spontaneous PTB in this population appears

Threatened preterm labor

Transvaginal ultrasound CL measurement may serve as an adjunct to digital cervical examination in the assessment of women with symptoms of acute PTL.51, 52, 53 Several observational studies have noted that the combination of CL and fetal fibronectin (FFN) assessment may improve prediction of PTB among women with symptoms of acute preterm labor.54, 55, 56 In triage units that combine CL screening and FFN testing in “symptomatic” patients, FFN does not add to PTB prediction in women with a very

References (69)

  • E.S. Miller et al.

    The association between cervical excisional procedures, midtrimester cervical length, and preterm birth

    Am J Obstet Gynecol

    (2014)
  • K. Dijkstra et al.

    Change in cervical length after cerclage as a predictor of preterm delivery

    Obstet Gynecol

    (2000)
  • E.F. Funai et al.

    Change in cervical length after prophylactic cerclage

    Obstet Gynecol

    (1999)
  • J.K. Baxter et al.

    Short cervical length after history-indicated cerclage: is a reinforcing cerclage beneficial?

    Am J Obstet Gynecol

    (2005)
  • K.M. Groom et al.

    Ultrasound-indicated cervical cerclage: outcome depends on preoperative cervical length and presence of visible membranes at time of cerclage

    Am J Obstet Gynecol

    (2002)
  • O.A. Rust et al.

    Does cerclage location influence perinatal outcome?

    Am J Obstet Gynecol

    (2003)
  • H.F. Andersen et al.

    Prediction of cervical cerclage outcome by endovaginal ultrasonography

    Am J Obstet Gynecol

    (1994)
  • E.R. Guzman et al.

    The significance of transvaginal ultrasonographic evaluation of the cervix in women treated with emergency cerclage

    Am J Obstet Gynecol

    (1996)
  • M.C. Gordon et al.

    Transvaginal cervical length scans to prevent prematurity in twins: a randomized controlled trial

    Am J Obstet Gynecol

    (2016)
  • R.L. Goldenberg et al.

    The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

    Am J Obstet Gynecol

    (1996)
  • K.H. Nicolaides et al.

    Cervical pessary placement for prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial

    Am J Obstet Gynecol

    (2016)
  • R. Gomez et al.

    Ultrasonographic examination of the uterine cervix is better than cervical digital examination as a predictor of the likelihood of premature delivery in patients with preterm labor and intact membranes

    Am J Obstet Gynecol

    (1994)
  • J.M. Crane et al.

    Transvaginal ultrasound in the prediction of preterm delivery: singleton and twin gestations

    Obstet Gynecol

    (1997)
  • R. Gomez et al.

    Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes

    Am J Obstet Gynecol

    (2005)
  • A. Ness et al.

    Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial

    Am J Obstet Gynecol

    (2007)
  • S. Mehra et al.

    Transvaginal cervical length and amniotic fluid index: can it predict delivery latency following preterm premature rupture of membranes?

    Am J Obstet Gynecol

    (2015)
  • S.J. Carlan et al.

    Randomized trial of endovaginal ultrasound in preterm premature rupture of membranes

    Obstet Gynecol

    (1997)
  • K. Lim et al.

    Ultrasonographic cervical length assessment in predicting preterm birth in singleton pregnancies

    J Obstet Gynaecol Can

    (2011)
  • L. Morin et al.

    Ultrasound in twin pregnancies

    J Obstet Gynaecol Can

    (2011)
  • World Health Organization Fact Sheet #363. November 2014. Available at:...
  • M.M. Adams et al.

    Rates of and factors associated with recurrence of preterm delivery

    JAMA

    (2000)
  • M.S. To et al.

    Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study

    Ultrasound Obstet Gynecol

    (2006)
  • V.C. Heath et al.

    Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery

    Ultrasound Obstet Gynecol

    (1998)
  • T.N. Leung et al.

    Cervical length at 18-22 weeks of gestation for prediction of spontaneous preterm delivery in Hong Kong Chinese women

    Ultrasound Obstet Gynecol

    (2005)
  • Cited by (179)

    • Universal cervical length screening: yes!

      2024, American Journal of Obstetrics and Gynecology MFM
    View all citing articles on Scopus

    All authors and Committee members have filed a conflict of interest disclosure delineating personal, professional, and/or business interests that might be perceived as a real or potential conflict of interest in relation to this publication. Any conflicts have been resolved through a process approved by the Executive Board. The Society for Maternal-Fetal Medicine has neither solicited nor accepted any commercial involvement in the development of the content of this publication.

    This document has undergone an internal peer review through a multi-level committee process within the Society for Maternal Fetal Medicine (SMFM). This review involves critique and feedback from the SMFM Publications and Risk Management Committees and final approval by the SMFM Executive Committee. SMFM accepts sole responsibility for document content. SMFM publications do not undergo editorial and peer review by the American Journal of Obstetrics & Gynecology. The SMFM Publications Committee reviews publications every 18-24 months and issues updates as needed. Further details regarding SMFM Publications can be found at www.smfm.org/ publications. All questions or comments regarding the document should be referred to the SMFM Publications Committee. at [email protected].

    View full text